chr8-43140508-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 2P and 11B. PM2BP4_StrongBP6_ModerateBP7BS1
The NM_152419.3(HGSNAT):c.12G>A(p.Ala4Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,058,390 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00077 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000045 ( 1 hom. )
Consequence
HGSNAT
NM_152419.3 synonymous
NM_152419.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.412
Genes affected
HGSNAT (HGNC:26527): (heparan-alpha-glucosaminide N-acetyltransferase) This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 8-43140508-G-A is Benign according to our data. Variant chr8-43140508-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 761828.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.412 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000769 (114/148192) while in subpopulation AFR AF= 0.00267 (110/41144). AF 95% confidence interval is 0.00227. There are 0 homozygotes in gnomad4. There are 47 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGSNAT | ENST00000379644.9 | c.12G>A | p.Ala4Ala | synonymous_variant | 1/18 | 2 | NM_152419.3 | ENSP00000368965.4 | ||
HGSNAT | ENST00000520704.1 | n.-139G>A | non_coding_transcript_exon_variant | 1/10 | 1 | ENSP00000429109.1 | ||||
HGSNAT | ENST00000520704.1 | n.-139G>A | 5_prime_UTR_variant | 1/10 | 1 | ENSP00000429109.1 | ||||
HGSNAT | ENST00000517319.1 | n.12G>A | non_coding_transcript_exon_variant | 1/5 | 4 | ENSP00000430032.1 |
Frequencies
GnomAD3 genomes AF: 0.000770 AC: 114AN: 148084Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
114
AN:
148084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000450 AC: 41AN: 910198Hom.: 1 Cov.: 29 AF XY: 0.0000398 AC XY: 17AN XY: 426748
GnomAD4 exome
AF:
AC:
41
AN:
910198
Hom.:
Cov.:
29
AF XY:
AC XY:
17
AN XY:
426748
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000769 AC: 114AN: 148192Hom.: 0 Cov.: 32 AF XY: 0.000651 AC XY: 47AN XY: 72230
GnomAD4 genome
AF:
AC:
114
AN:
148192
Hom.:
Cov.:
32
AF XY:
AC XY:
47
AN XY:
72230
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Mucopolysaccharidosis, MPS-III-C Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
Mucopolysaccharidosis, MPS-III-C;C4225287:Retinitis pigmentosa 73 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at